Evidence map›Paper›PMID 32794009›Full record

ArticleJournal of cancer survivorship : research and practice2021

Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.

Beth A Glenn, Narissa J Nonzee, Ann S Hamilton, Lina Tieu, Annette E Maxwell, Catherine M Crespi, L Cindy Chang, Dennis Deapen, Roshan Bastani

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Beth A GlennUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA. bglenn@ucla.edu.ORCID 0000-0002-4937-8181
Narissa J NonzeeUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
Ann S HamiltonLos Angeles County Cancer Surveillance Program and Keck School of Medicine, University of Southern California, 2001 N. Soto Street, SSB318E, Los Angeles, CA, 90089-9239, USA.
Lina TieuUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
Annette E MaxwellUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
Catherine M CrespiUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
L Cindy ChangUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
Dennis DeapenLos Angeles County Cancer Surveillance Program and Keck School of Medicine, University of Southern California, 2001 N. Soto Street, SSB318E, Los Angeles, CA, 90089-9239, USA.
Roshan BastaniUCLA Center for Cancer Prevention and Control Research, UCLA Kaiser Permanente Center for Health Equity, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles, 650 Charles Young Drive South, A2-125 CHS, Los Angeles, CA, 90095-6900, USA.
Kaiser Permanente · USUniversity of Southern California · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA/RAND HEALTH SERVICES RESEARCH TRAINING PROGRAMT32HS000046 · AHRQ · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EISENBERG, DANIEL · 1992 to 2024
$8.7M
NRSA Training CoreTL1TR001883 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, Nina Thawata Harawa · 2016 to 2026
$8.6M
UCLA/RAND PREVENTION RESEARCH CENTERU48DP001934 · DP · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BASTANI, ROSHAN · 2009 to 2013
$5.9M
UCLA Clinical and Translational Science InstituteTL1TR000121 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$2.7M
AHRQ HHS T32 HS000046CDC HHS U48 DP001934/SIP11-044NCATS NIH HHS TL1 TR000121NCATS NIH HHS TL1 TR001883NCCDPHP CDC HHS NU58DP006344NCCDPHP CDC HHS U48 DP001934NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS P30 CA016042NCI NIH HHS P30 CA16042
6 · The paper itself

Abstract

purposeCancer survivors diagnosed at an early age remain at risk for cancer recurrence and other chronic diseases. This study assessed engagement in surveillance for recurrence, cancer screening, and other recommended preventive health services among breast and colorectal cancer survivors with early-onset disease (≤ 50 years) who were diagnosed in California.

methodsBreast and colorectal cancer survivors diagnosed with early-onset cancer between 1999 and 2009 were identified through the California Cancer Registry, the state-based cancer registry, and surveyed. Multivariable regression analyses were used to assess correlates of receipt of cancer surveillance, cancer screening, and other preventive health services.

resultsOf the 497 survivors that were invited to participate in the study, 156 completed the survey for a response rate of 31%. The sample was 50 years of age on average (range 32-69 years) with a mean time since diagnosis of 9 years. The majority of the sample (71%) was a racial/ethnic minority (24% Latino, 15% African American, 29% Asian). Overall, 80% received appropriate surveillance for recurrence, and 72% received recommended screening for early detection of other cancers (breast, cervical, colorectal). Increasing age was associated with lower likelihood of early detection screening (adjusted odds ratio (aOR) 0.28, 95% confidence interval (CI) 0.11-0.69), and higher income was associated with a greater likelihood (aOR 4.89, 95% CI 1.62-14.81). Screening rates were highest for blood pressure (96%), cholesterol (86%), and diabetes (81%), followed by dental visits (64%) and flu vaccination (35%). Greater use of recommended preventive health services was associated with increasing age, female sex, higher education level, and having health insurance.

conclusionsAlthough the majority of survivors received appropriate surveillance for recurrence, engagement in other preventive health services varied substantially. IMPLICATIONS FOR CANCER SURVIVORS: Efforts are needed to address gaps in the use of recommended cancer screening and preventive health services among cancer survivors, particularly survivors with early-onset disease who may be at increased risk for additional cancers and common chronic conditions over their lifetime.

Indexed as

Cancer SurvivorsColorectal NeoplasmsAdultAgedEthnicityFemaleHumansMiddle AgedMinority GroupsPreventive Health ServicesSurvivorsCancer screeningCancer surveillanceCancer survivorsMinority groupsPreventive health services

Identifiers

PMID32794009
PMCPMC7882005
OpenAlexW3049083186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.